Market Place
Sourcing Support
All News #Library
Biotech
Blue Lake Bio To Restart Phase 1/2A Trial For BLB201
21 Nov 2025 //
BUSINESSWIRE
Blue Lake, CyanVac Share Full COVID-19 Vax Phase 1 Data
07 Jul 2025 //
BUSINESSWIRE
Intranasal COVID-19 Vaccine Shows Durable Immune Response
27 Mar 2025 //
BUSINESSWIRE
Blue Lake Biotechnology to Present RSV Vaccine Data at Symposium
10 Mar 2025 //
BUSINESSWIRE
Blue Lake Biotech Reports Data For RSV Vaccine BLB201 In Kids
12 Dec 2024 //
BUSINESSWIRE
Blue Lake and CyanVac Present at Society for Vaccines Congress
21 Oct 2024 //
BUSINESSWIRE
Blue Lake Reports Positive Clinical Data in Children for Its RSV Vaccine
21 Mar 2024 //
BUSINESSWIRE
Phase 1 Data for Blue Lake Biotechnology’s Intranasal RSV Vaccine Published
25 Oct 2023 //
BUSINESSWIRE
Blue Lake to highlight preliminary COVID Phase 1 data at BIO CEO Conference
06 Feb 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.